The company’s reflux management system comprises a small flexible band of interlinked titanium beads with magnetic cores, which is laparoscopically placed around the esophageal sphincter.
The magnetic attraction between the beads will help the sphincter resist opening to gastric pressure, preventing reflux from the stomach into the esophagus.
Torax Medical CEO Todd Berg said they look forward to working with the FDA to reach a final decision on approval to make the LINX treatment available to patients in US.
US-based Torax Medical is focused on developing and marketing products designed to treat sphincter disorders.
